<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Cancer and inflammation mechanisms : chemical, biological, and clinical aspects</title>
  </titleInfo>
  <name type="personal">
    <namePart>Hiraku, Yūsuke</namePart>
    <role>
      <roleTerm type="text">editor.</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Kawanishi, Shōsuke</namePart>
    <namePart type="date">1942-</namePart>
    <role>
      <roleTerm type="text">editor.</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Ōshima, Hiroshi</namePart>
    <namePart type="date">1949-</namePart>
    <role>
      <roleTerm type="text">editor.</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <genre authority="">Electronic books.</genre>
  <genre authority="">Electronic books.</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">nju</placeTerm>
    </place>
    <dateIssued encoding="marc">2014</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="gmd">electronic resource</form>
    <extent>1 online resource (xvi, 383 pages) : illustrations</extent>
  </physicalDescription>
  <tableOfContents>Titlepage; Copyright; Contents; CONTRIBUTORS; PREFACE; CHAPTER 1 INFECTION, INFLAMMATION, AND CANCER: OVERVIEW; INFECTION, INFLAMMATION, AND CANCER: POSSIBLE MECHANISMS; PRODUCTION OF INFLAMMATORY MEDIATORS AND REACTIVE OXIDANTS; DNA AND PROTEIN DAMAGE BY ROSs AND RNSs; INFLAMMATION, EPIGENETIC MODIFICATION, AND microRNA; CONCLUDING REMARKS; REFERENCES; CHAPTER 2 STEM CELL THEORY AND INFLAMMATION-RELATED CANCER; CHRONIC INFLAMMATION AND CANCER; CANCER STEM CELLS; CARCINOGENIC FACTORS ARISING FROM CHRONIC INFLAMMATION; CHRONIC INFLAMMATION AND NORMAL STEM CELL FUNCTION</tableOfContents>
  <tableOfContents>Inflammation and the development and regulation of cancer stem cellsconcluding remarks; references; chapter 3 epithelial-mesenchymal transition: a link between cancer and inflammation; emt: a link between cancer and inflammation; q1: how are emt-permissive, inflammatory tumor microenvironments created?; q2: which emt-promoting signals are provided by inflammatory tumor microenvironments?; q3: how do emt-promoting signals influence the migratory behavior of tumor cells?; conclusions and future prospects; references; chapter 4 role of nitrative dna damage in inflammation- related carcinogenesis</tableOfContents>
  <tableOfContents>Dna damage during chronic inflammationliver fluke-induced cholangiocarcinoma; hpv-induced cervical cancer; ebv-induced nasopharyngeal carcinoma; dna damage induced by asbestos exposure; dna damage induced by carbon nanotube; soft tissue tumors and prognosis of tumor patients; conclusions and future prospects; references; chapter 5 lipid peroxidation-derived dna adducts and the role in inflammation-related carcinogenesis; lpo-derived reactive products contribute to dna damage; results and discussion; conclusions and future prospects; references</tableOfContents>
  <tableOfContents>CHAPTER 6 LEVEL OF INFLAMMATION-RELATED DNA ADDUCTS IN HUMAN TISSUESLEVEL OF 4-ONE- AND 4-OHE-DERIVED DNA ADDUCTS IN HUMAN TISSUES; BIOLOGICAL PROPERTIES OF 4-ONE- AND 4-OHE-DERIVED DNA ADDUCTS; INFLAMMATION AND FORMATION OF 4-ONE; CONCLUDING REMARKS; REFERENCES; CHAPTER 7 TOLL-LIKE RECEPTORS: ROLE IN INFLAMMATION AND CANCER; TLRs AND THEIR LIGANDS; TLR SIGNALING; MYD88-DEPENDENT SIGNALING PATHWAYS; TRIF-DEPENDENT SIGNALING PATHWAYS; INNATE IMMUNE CELLS IN CANCER TISSUES; TLRs AND TUMOR MICROENVIRONMENT; TOLL-LIKE RECEPTORS IN CANCER AND TUMOR THERAPY; ANTITUMOR ACTIVITY OF TLR LIGANDS</tableOfContents>
  <tableOfContents>ROLES OF TLRs IN CANCER PROGRESSIONCURRENT AND FUTURE DEVELOPMENTS; REFERENCES; CHAPTER 8 INFLAMMASOMES AND INFLAMMATION; NOD-LIKE RECEPTORS AND THE INFLAMMASOMES; THE NLRP3 INFLAMMASOME; THE IPAF INFLAMMASOME; THE NLRP1 INFLAMMASOME; THE NLRP12 INFLAMMASOME; THE NLRP7 INFLAMMASOME; THE NLRP6 INFLAMMASOME; THE AIM2 INFLAMMASOME; CYTOKINE TARGETS OF THE INFLAMMASOME; INFLAMMASOME DYSREGULATION IN DISEASE; CONCLUDING REMARKS; REFERENCES; CHAPTER 9 ACTIVATION-INDUCED CYTIDINE DEAMINASE: AN INTRINSIC GENOME MODULATOR IN INFLAMMATION-ASSOCIATED CANCER DEVELOPMENT</tableOfContents>
  <note type="statement of responsibility">edited by Dr. Yusuke Hiraku, Dr. Shosuke Kawanishi, Dr. Hiroshi Ohshima.</note>
  <note>Includes index.</note>
  <note>Includes bibliographical references and index.</note>
  <subject authority="lcsh">
    <topic>Carcinogenesis</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Inflammation</topic>
    <topic>Mediators</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Inflammation</topic>
    <topic>Immunological aspects</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Cancer</topic>
    <topic>Immunological aspects</topic>
  </subject>
  <subject authority="mesh">
    <topic>Neoplasms</topic>
    <topic>genetics</topic>
  </subject>
  <subject authority="bisacsh">
    <topic>HEALTH &amp; FITNESS</topic>
    <topic>Diseases</topic>
    <topic>General</topic>
  </subject>
  <subject authority="bisacsh">
    <topic>MEDICAL</topic>
    <topic>Clinical Medicine</topic>
  </subject>
  <subject authority="bisacsh">
    <topic>MEDICAL</topic>
    <topic>Diseases</topic>
  </subject>
  <subject authority="bisacsh">
    <topic>MEDICAL</topic>
    <topic>Evidence-Based Medicine</topic>
  </subject>
  <subject authority="bisacsh">
    <topic>MEDICAL</topic>
    <topic>Internal Medicine</topic>
  </subject>
  <subject authority="fast">
    <topic>Cancer</topic>
    <topic>Immunological aspects</topic>
  </subject>
  <subject authority="fast">
    <topic>Carcinogenesis</topic>
  </subject>
  <subject authority="fast">
    <topic>Inflammation</topic>
    <topic>Immunological aspects</topic>
  </subject>
  <subject authority="fast">
    <topic>Inflammation</topic>
    <topic>Mediators</topic>
  </subject>
  <subject>
    <topic>Inflammation - Immunological aspects</topic>
  </subject>
  <classification authority="lcc">RC268.5</classification>
  <classification authority="ddc" edition="23">616.99/401</classification>
  <classification authority="nlm">QZ 202</classification>
  <relatedItem type="otherFormat" displayLabel="Print version:">
    <titleInfo>
      <title>Cancer and inflammation mechanisms</title>
    </titleInfo>
    <originInfo>
      <publisher>Hoboken, New Jersey : Wiley, [2014]</publisher>
    </originInfo>
    <identifier type="local">(DLC)  2013035524</identifier>
    <identifier type="local">(OCoLC)859252945</identifier>
  </relatedItem>
  <identifier type="isbn">9781118826553</identifier>
  <identifier type="isbn">1118826558</identifier>
  <identifier type="isbn">9781118826676</identifier>
  <identifier type="isbn">1118826671</identifier>
  <identifier type="isbn">9781118826621</identifier>
  <identifier type="isbn">1118826620</identifier>
  <identifier type="isbn">9781306533058</identifier>
  <identifier type="isbn">1306533058</identifier>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="lccn">2013039801</identifier>
  <identifier type="uri">http://onlinelibrary.wiley.com/book/10.1002/9781118826621</identifier>
  <location>
    <url>http://onlinelibrary.wiley.com/book/10.1002/9781118826621</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">DLC</recordContentSource>
    <recordCreationDate encoding="marc">130930</recordCreationDate>
    <recordChangeDate encoding="iso8601">20171106082828.0</recordChangeDate>
    <recordIdentifier source="OCoLC">ocn859253561</recordIdentifier>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
